<DOC>
	<DOCNO>NCT02163889</DOCNO>
	<brief_summary>The objective study investigate T2Candida performance monitor tool post-therapy clearance Candida compare blood culture . This study collect T2clinical specimen companion blood culture patient exhibit positive blood culture gram stain yeast , receive treatment antifungal therapy .</brief_summary>
	<brief_title>Serial Therapeutic Antifungal Monitoring Protocol</brief_title>
	<detailed_description>One blood culture one set T2clinical specimen collect specified interval monitor clearance Candida infection bloodstream . Each T2 result compare companion blood culture result . The comparison determine presence antifungal therapy inhibits blood culture lead incidence blood culture false negative test result . The T2 result , impact presence antifungal therapy , show pathogen still present additional period time .</detailed_description>
	<mesh_term>Candidemia</mesh_term>
	<mesh_term>Antifungal Agents</mesh_term>
	<mesh_term>Miconazole</mesh_term>
	<criteria>Subject subject 's authorized representative must able understand , read sign study specific informed consent form nature study fully explain . Subject 1895 year age Subject blood culture result positive yeast within 36 hour enrollment Subject comorbid condition ( ) , opinion Investigator , could limit subject 's ability participate study impact scientific integrity study All T2 Bio individual clinical research specimens contain &lt; 3 ml blood Use novel ( i.e . commercially available ) drug compound within 30 day prior collection T2 Bio blood specimen .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Candida</keyword>
	<keyword>Blood culture</keyword>
	<keyword>Antifungal therapy</keyword>
	<keyword>Sepsis</keyword>
</DOC>